ExploreWatchlistsPricing
  1. JP-listed companies
  2. SYSMEX CORPORATION
  3. Financials
  4. Free cash flow

SYSMEX CORPORATION (6869)

Market cap
¥873.7B
P/E ratio
21.1x
Develops and manufactures medical testing equipment and reagents for blood tests and urinalysis, serving healthcare institutions worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndFree cash flow (Million JPY)YoY (%)
Mar 31, 202559,020+54.12%
Mar 31, 202438,295-25.42%
Mar 31, 202351,350+11.70%
Mar 31, 202245,971-5.96%
Mar 31, 202148,883+23.59%
Mar 31, 202039,553+52.03%
Mar 31, 201926,017-27.06%
Mar 31, 201835,667+37.81%
Mar 31, 201625,882+1.07%
Mar 31, 201525,607

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat